Skip to main content

Market Overview

31 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

Diana Containerships Inc (NASDAQ: DCIX) shares jumped 90.1 percent to $21.31 on no news. Diana Containerships shares rallied nearly 700 percent on Friday.

TOP SHIPS Inc (NASDAQ: TOPS) shares surged 89.7 percent to $1.37 on no news.

TherapeuticsMD Inc (NASDAQ: TXMD) climbed 52.4 percent to $6.64 after the company reported a plan to resubmit the New Drug Application for TX-004HR. TherapeuticsMD reported a Q3 loss of $0.07 per share on revenue of $4.41 million.

Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares gained 22.6 percent to $11.83. Helios and Matheson will issue institutional investors $100 million in convertible notes to pay off $5 million owed to MoviePass and increase its stake with an additional $20 million through a previously reported Investment Option Agreement.

Tel-Instrument Electronics Corp. (NYSE: TIK) rose 17.7 percent to $2.84.

Reata Pharmaceuticals Inc (NASDAQ: RETA) gained 14 percent to $32.98. Reata reported that Phase 2 CARDINAL study met primary endpoint of change in EGFR at 12 weeks.

Michael Kors Holdings Ltd (NYSE: KORS) climbed 13.8 percent to $54.20 after the company reported better-than-expected results for its second quarter and raised its 2018 forecast.

Basic Energy Services, Inc. (NYSE: BAS) shares rose 12.2 percent to $22.56 on narrower-than-expected Q3 loss.

Vascular Biogenics Ltd (NASDAQ: VBLT) climbed 11.4 percent to $6.85. Nanocarrier signed an exclusive agreement with VBL Therapeutics for VB-111 in Japan.

Cavium Inc (NASDAQ: CAVM) climbed 11.2 percent to $75.90. Marvell Technology is in advanced talks to merge with Cavium, the Wall Street Journal reported.

Twin Disc, Incorporated (NASDAQ: TWIN) surged 11.1 percent to $ 25.21.

Marvell Technology Group Ltd. (NASDAQ: MRVL) shares gained 9.1 percent to $20.19. Marvell Technology is in advanced talks to merge with Cavium Inc (NASDAQ: CAVM), the Wall Street Journal reported.

Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH) shares climbed 8 percent to $17.00. B. Riley initiated coverage on Spring Bank Pharma with a Buy rating and a $30.00 price target.

Flex Pharma Inc (NASDAQ: FLKS) rose 6.3 percent to $3.53 as the company posted narrower-than-expected Q3 loss.

Losers

Medical Transcription Billing Corp (NASDAQ: MTBC) dropped 23.3 percent to $3.06. MTBC reported a Q3 loss of $0.14 per share on sales of $7.51 million.

PAR Technology Corporation (NYSE: PAR) declined 18.3 percent to $ 8.94. PAR Technology is expected to release quarterly results on November 13.

Finjan Holdings, Inc. (NASDAQ: FNJN) shares fell 17.4 percent to $1.73. Finjan is expected to release Q3 results on November 9.

Novogen Limited (ADR) (NASDAQ: NVGN) shares declined 15.4 percent to $2.39.

Sprint Corp (NYSE: S) dropped 13.7 percent to $5.76 as T-Mobile and Sprint officially end merger discussions. KeyBanc downgraded Sprint from Sector Weight to Underweight.

Neos Therapeutics Inc (NASDAQ: NEOS) shares fell 13.1 percent to $11.21.

Mesa Laboratories, Inc. (NASDAQ: MLAB) shares declined 10 percent to $142.04 on weaker-than-expected quarterly results.

Ceragon Networks Ltd (NASDAQ: CRNT) fell 9.6 percent to $1.88. Ceragon reported Q3 earnings of $0.05 per share on sales of $76 million.

Henry Schein, Inc. (NASDAQ: HSIC) dropped 8.9 percent to $70.78 as the company posted downbeat quarterly earnings.

CYANOTECH CORP (NASDAQ: CYAN) shares declined 8.9 percent to $4.42. Cyanotech reported Q2 earnings of $0.08 per share on sales of $8.05 million.

Hydrogenics Corporation (USA) (NASDAQ: HYGS) shares fell 7.2 percent to $9.70. Hydrogenics reported a Q3 loss of $0.13 per share on sales of $12.2 million.

Gray Television, Inc. (NYSE: GTN) dropped 6.2 percent to $14.40 on weak quarterly earnings.

Horizon Pharma PLC (NASDAQ: HZNP) shares fell 6 percent to $13.33 as the company posted strong Q3 results and raised its FY17 outlook.

T-Mobile US Inc (NASDAQ: TMUS) shares dropped 5.2 percent to $55.83. T-Mobile and Sprint officially end merger discussions.

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) shares fell 5 percent to $3.05. AVEO Oncology and EUSA Pharma disclosed promising Phase 1 results from the Phase 1/2 TiNivo study of tivozanib and nivolumab in renal cell carcinoma.

ON Semiconductor Corp (NASDAQ: ON) declined 3.6 percent to $20.88 after the company posted downbeat quarterly earnings.

 

Related Articles (BAS + AVEO)

View Comments and Join the Discussion!

Posted-In: Mid-Day Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com